Mid-Atlantic Bio

Sep 03, 2010

Biotechnology Investments in Today’s Economy: Frederick Frank to Address Mid-Atlantic Bio Conference

WASHINGTON (September 3, 2010)—Frederick Frank, one of the most significant dealmakers in the biotech and pharma industry’s history and current vice chairman of Peter J. Solomon Company, will address the 2010 Mid-Atlantic Bio Conference (Oct. 27-29), on October 28, at the North Bethesda Marriott Convention Center in Bethesda, Md.

Mr. Frank is credited as one of the leading investment bankers worldwide for pharmaceutical, biotechnology, healthcare services, medical device and nutraceutical company mergers, acquisitions, strategic alliances and equity fundraising. With his wealth of experience, Mr. Frank will provide insight to how the industry is coping in today’s volatile economic climate and what needs to evolve to compete in today’s markets.

In addition to Mr. Frank’s role as vice chairman of Peter J. Solomon Company, he is also a member of its Mergers and Acquisitions Group, and co-heads PJSC’s global pharmaceutical and life sciences practice. He was formerly vice chairman of Barclays Capital, and previous to that, was vice chairman and a director of Lehman Brothers Inc. Before joining Lehman Brothers as partner, Mr. Frank was co-director of research, as well as vice president and director of Smith, Barney & Co. Incorporated.

Now in its sixth year, Mid-Atlantic Bio is the only globally-focused, yet regionally-based, event to combine components of a bioscience industry convention with an investor conference under one roof. More than 800 national and international industry leaders, government representatives, executives, researchers, investors, entrepreneurs, and professional services firms will gather to promote networking, business expansion, and technical-knowledge sharing. Home to industry-critical regulatory and research agencies; federal policymaking; and business and scientific centers of excellence, the Mid-Atlantic is a unique center for the global bioscience industry.

“Our regional biotechnology industry is increasingly recognized as a hub for scientific progress and excellence,” said Mid-Atlantic Venture Association (MAVA) Executive Director Julia Spicer. “Mid-Atlantic Bio brings together the region’s biotechnology community to offer one of the most in-depth networking and educational forums for the life sciences industry. Conference participants leave the meeting with the right connections to build their businesses.”

Conference Sessions:
Designed to be a platform that brings together science, company builders, commercial interests and collaborators, capital sources, and federal and regulatory thought-leaders, the 2010 program includes a variety of important industry topics—ranging from the latest in policy and regulatory matters, business and financing opportunities, and CEO War Stories to advances in science and technology—and showcases exciting companies from the biosciences field. A few of the highlighted sessions include:

•An Insider’s View on Washington
•Synthetic Biology – Applications and Implications
•Accessing the Regulatory Risk: Your Path to Approval
•CEO Roundtable

Company Presentations:
Each year at Mid-Atlantic Bio, a number of life science companies are chosen to present before an audience of capital sources, including corporate business development professionals, peer scientists and company leaders, venture capitalists, angel investors, and various other qualified financing sources along with important industry professionals and potential strategic partners.

BioMatch:
Mid-Atlantic Bio’s signature networking program, BioMatch, is designed specifically for the life sciences and biotech industries, and provides registered attendees access to advanced partnering software that facilitates personalized, one-on-one meetings between the leading bioscience organizations and industry leaders.

Partial List of Conference Sponsors:
Cooley LLP, Hogan Lovells US LLP, Grant Thornton LLP, MedImmune, Wilson Sonsini Goodrich & Rosati, E&Y, BioMed Realty Trust, Inc., Alexandria Real Estate Equities, Inc., Janelia Farms Research Campus of Howard Hughes Medical Institute, NIH Federal Credit Union, Virginia Tech, Deloitte & Touche LLP, Intersouth Partners, Oxford Finance, TEDCO

# # #

ABOUT MID-ATLANTIC BIO
Mid-Atlantic Bio is co-hosted by the MdBio Division of the Tech Council of Maryland (TCM), the Mid-Atlantic Venture Association (MAVA), and the Virginia Biotechnology Association (VaBIO). Mid-Atlantic Bio benefits from broad regional support from the investor and greater business communities, academic institutions, government agencies, and partnering regional associations. For more information, or to register or sponsor, please visit http://midatlanticbio.org.

# # #